Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors

被引:19
|
作者
Kanamori, Masayuki [1 ]
Kumabe, Toshihiro [1 ]
Sonoda, Yukihiko [1 ]
Nishino, Yoshikazu [2 ]
Watanabe, Mika [3 ]
Tominaga, Teiji [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Natori, Miyagi 9811293, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan
关键词
Oligodendroglioma; Dissemination; Predictive factors; Nestin Ki-67; LOW-GRADE OLIGODENDROGLIOMAS; PHASE-III TRIAL; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; GLIOMAS; CHEMOTHERAPY; RADIOTHERAPY; MARKERS; NESTIN;
D O I
10.1007/s11060-008-9762-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pattern of recurrence and predictive factors for tumor progression, dissemination and survival in oligodendroglial tumors were investigated. 56 consecutive patients with oligodendroglial tumors were retrospectively analyzed to determine the predictive significance of various factors, including World Health Organization grade, loss of chromosomes 1p and 19q, and immunohistochemical features of TP53, O-6-methylguanine-deoxyribonucleic-acid-methyltransferase, CD44H, nestin, and Ki-67. Eleven patients developed dissemination, and had significantly shorter post-progression survival compared to ten patients with local recurrence. Univariate analysis showed that retention of chromosome 1p or 19q, Ki-67 labeling index a parts per thousand yen 25%, diffuse expression of nestin, and p53 labeling index a parts per thousand yen 10% were unfavorable factors for overall, progression-free, and dissemination-free survival. Multivariate analysis showed that Ki-67 labeling index a parts per thousand yen 25% and diffuse expression of nestin were significant for dissemination-free survival. In conclusion, post-progression survival shows significant differences between patients with local and disseminated recurrence. Ki-67 labeling index and nestin expression pattern are useful markers to predict dissemination.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 50 条
  • [1] Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors
    Masayuki Kanamori
    Toshihiro Kumabe
    Yukihiko Sonoda
    Yoshikazu Nishino
    Mika Watanabe
    Teiji Tominaga
    Journal of Neuro-Oncology, 2009, 93 : 219 - 228
  • [2] Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer
    Petrelli, F.
    Barni, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 186 - 192
  • [3] Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
    Bridgewater, J.
    Lopes, A.
    Wasan, H.
    Malka, D.
    Jensen, L.
    Okusaka, T.
    Knox, J.
    Wagner, D.
    Cunningham, D.
    Shannon, J.
    Goldstein, D.
    Moehler, M.
    Bekaii-Saab, T.
    McNamara, M. G.
    Valle, J. W.
    ANNALS OF ONCOLOGY, 2016, 27 (01) : 134 - 140
  • [4] Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas
    Sagberg, Lisa Millgard
    Salvesen, Oyvind
    Jakola, Asgeir Store
    Thurin, Erik
    de Dios, Eddie
    Nawabi, Noah L. A.
    Kilgallon, John L.
    Bernstock, Joshua D.
    Kavouridis, Vasileios K.
    Smith, Timothy R.
    Solheim, Ole
    ACTA ONCOLOGICA, 2024, 63 : 798 - 804
  • [5] Effect of Zinc Sulfate on Overall Survival and Progression-Free Survival in Patients with Glioblastoma Multiforme, a Phase II Study
    Ahmadloo, Niloofar
    Kameli, Parisa
    Ansari, Mansour
    Mosalaei, Ahmad
    Omidvari, Shapour
    Nasrollahi, Hamid
    Hamedi, Seyed Hassan
    Mohammadianpanah, Mohammad
    MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (01) : 113 - 118
  • [6] Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer
    Gagno, Sara
    Bartoletti, Michele
    Romualdi, Chiara
    Poletto, Elena
    Scalone, Simona
    Sorio, Roberto
    Zanchetta, Martina
    De Mattia, Elena
    Roncato, Rossana
    Cecchin, Erika
    Giorda, Giorgio
    Toffoli, Giuseppe
    PHARMACOGENOMICS, 2020, 21 (14) : 995 - 1010
  • [7] Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
    Chowdhury, Simon
    Mainwaring, Paul
    Zhang, Liangcai
    Mundle, Suneel
    Pollozi, Eneida
    Gray, Alexander
    Wildgust, Mark
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [8] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
  • [9] Stem Cell Markers in Neoplasms and their Relationship with Progression-free and Overall Survival in Patients with Recurrence
    Eguiluz-Melendez, Aldo
    Rubio-Osornio, Carmen
    Rosiles-Abonce, Artemio
    Mendoza, Cesar
    Ramirez-Ordas, Miryam
    Rivera-Canas, Romina
    Tena-Suck, Martha
    Gomez-Amador, Juan Luis
    Moreno-Jimenez, Sergio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024,
  • [10] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063